Eris Lifesciences Limited announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced total revenue was INR 3,320.76 million compared to INR 2,899.64 million a year ago. Net income was INR 1,077.2 million compared to INR 927.11 million a year ago. Basic earnings per share from continuing operations was INR 7.93 compared to INR 6.74 a year ago. Diluted earnings per share from continuing operations was INR 7.93 compared to INR 6.73 a year ago. For the half year, total revenue was INR 6,266.57 million compared to INR 5,670.9 million a year ago. Net income was INR 1,967.38 million compared to INR 1,767.56 million a year ago. Basic earnings per share from continuing operations was INR 14.49 compared to INR 12.85 a year ago. Diluted earnings per share from continuing operations was INR 14.48 compared to INR 12.84 a year ago.